What is the main business of Thoc Medi?

The main business activity of Thoc Medi focuses on research and experimental development on biotechnology.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on August 18, 2020.

Where is the headquarters located?

The headquarters is located at: ul. Mogilska 35, 31-545 Kraków.

What is the share capital?

The share capital of the company is PLN 15,000 (approx. $4,052).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What was the revenue?

The company reported a revenue of $57,513 in 2025, which is a decrease of 28.6% compared to 2024.

Yes, in 2025 the company was profitable, achieving a net profit of $2,615.

Which cost dominates operating expenses?

The largest operating cost category falls under employee remuneration. This category amounted to $30,513 in 2025, representing 59% of all operating expenses.

Thocsp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2020-08-18

Share capital

15 000,00 PLN

Registered address

ul. Mogilska 35, 31-545 Kraków, Poland

Financials

Revenue history (in k)

Filing timeliness

2 of 5 financial statements were filed late (the longest delay 39 days for 2021).

202512/06/2026
202424/06/2025
202317/07/2024
202230/06/2023
202123/08/2022

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 57.51kMedianUSD 55.24kAverageUSD 2.71m

Net profit

This companyUSD 2.62kMedianUSD -1.27kAverageUSD -91.85k

Operating costs

This companyUSD 51.74kMedianUSD 65.85kAverageUSD 2.66m

Assets

This companyUSD 17.03kMedianUSD 133.19kAverageUSD 3.03m

Industry

Authorized Representatives

Robert Janusz Baran – Management Board Member

Jakub Silarow – Management Board Member

Michał Kachel – Management Board Member

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

Owner	Shares	Share value	Stake
Robert Janusz Baranage 36	102	$1,377.63	34%
Michał Kachelage 38	96	$1,296.60	32%
Jakub Silarowage 43	102	$1,377.63	34%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2021-02-08.

mBank
83 1140 2004 0000 3202 8090 2235

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
MedappS.A.	$3,351,163.61	medapp.pl
SkinlabP.S.A.	$1,797,229.06	skinlab.pl
EIT Rawmaterials Clc Eastsp. z o.o.	$1,795,803.10	eitrawmaterials.eu
COS LabP.S.A.	$1,028,123.83	coslab.pl
IntelliseqS.A.	$111,419.60	intelliseq.pl
Przedsiębiorstwo Wielobranżowe Genezasp. z o.o.	$54,163.54	geneza.eu
Medtransfersp. z o.o.	$21,666.01	codete.com
Oncotherics PolandS.A.	$7,565.33	oncotherics.com
Fusiomicasp. z o.o.	$5,263.98	fusiomica.com
Ncage TherapeuticsS.A.	$29.14	ncage.org